NIH Consensus Development Conference: Inhaled Nitric Oxide Therapy for Premature Infants F. Sessions Cole, M.D. Panel and Conference Chairperson Dr. Cole is the Park J. White, M.D. Professor of Pediatrics, Vice Chancellor for Children’s Health, and Vice Chairperson for the Department of Pediatrics, and the Director of the Division of Newborn Medicine at the Washington University School of Medicine. He is also the Chief Medical Officer of the St. Louis Children’s Hospital. Dr. Cole’s research interests focus on understanding the genetic mechanisms that disrupt pulmonary surfactant metabolism and cause neonatal respiratory distress
NIH Consensus Development Conference: Inhaled Nitric Oxide Therapy for Premature Infants
Feb 02, 2016
NIH Consensus Development Conference: Inhaled Nitric Oxide Therapy for Premature Infants. F. Sessions Cole, M.D. Panel and Conference Chairperson. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
NIH Consensus Development Conference:Inhaled Nitric Oxide Therapy for Premature
Infants
F. Sessions Cole, M.D.
Panel and Conference Chairperson
Dr. Cole is the Park J. White, M.D. Professor of Pediatrics, Vice Chancellor for Children’s Health, and Vice Chairperson for the Department of Pediatrics, and the Director of the Division of Newborn Medicine at the Washington University School of Medicine. He is also the Chief Medical Officer of the St. Louis Children’s Hospital. Dr. Cole’s research interests focus on understanding the genetic mechanisms that disrupt pulmonary surfactant metabolism and cause neonatal respiratory distress syndrome.
Related Documents
